Robert Andrade - 28 Dec 2022 Form 4 Insider Report for FENNEC PHARMACEUTICALS INC. (FENC)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Robert Andrade
Issuer symbol
FENC
Transactions as of
28 Dec 2022
Net transactions value
-$211,288
Form type
4
Filing time
30 Dec 2022, 15:42:58 UTC
Previous filing
22 Sep 2022
Next filing
25 Mar 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FENC Common shares Sale $105,760 -11,000 -6.4% $9.61 160,721 28 Dec 2022 Direct F1
transaction FENC Common shares Sale $52,661 -5,500 -3.4% $9.57 155,221 29 Dec 2022 Direct F2
transaction FENC Common shares Sale $52,867 -5,500 -3.5% $9.61 149,721 30 Dec 2022 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold pursuant to a 10b5-1 plan on December 28, 2022.
F2 Represents shares sold pursuant to a 10b5-1 plan on December 29, 2022.
F3 Represents shares sold pursuant to a 10b5-1 plan on December 30, 2022.